Davis Polk advised the sole underwriter in connection with the SEC-registered follow-on public offering of 4,444,445 ordinary shares sold by Quotient Limited (“Quotient”). Total gross proceeds from the offering were approximately $36.9 million. Quotient’s ordinary shares are listed on the NASDAQ Global Market under the symbol “QTNT.”
Quotient is a commercial-stage diagnostics company committed to reducing healthcare costs and improving patient care through the provision of innovative tests within established markets. The company’s operations are based in Edinburgh, Scotland; Eysins, Switzerland; and Newtown, Pennsylvania.
The Davis Polk corporate team included partner Alan F. Denenberg and associates Pedro J. Bermeo and Martin Oberst. Partner Rachel D. Kleinberg and associate Alexander Wu provided tax advice. Counsel Marcie A. Goldstein provided FINRA advice. Members of the Davis Polk team are based in the Northern California and New York offices.